Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -925.63 Million CNY | -4.84% |
| 2022 | -882.92 Million CNY | -12.84% |
| 2021 | -782.42 Million CNY | -15.47% |
| 2020 | -677.6 Million CNY | 54.24% |
| 2019 | -1.48 Billion CNY | -328.81% |
| 2018 | -345.3 Million CNY | -191.36% |
| 2017 | -118.51 Million CNY | -9.9% |
| 2016 | -107.83 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -35.83 Million USD | -29.25% |
| 2023 Q4 | -36.86 Million USD | -2.86% |
| 2023 Q1 | -29.29 Million USD | 15.14% |
| 2023 FY | -925.63 Million CNY | -4.84% |
| 2023 Q2 | -27.72 Million USD | 5.35% |
| 2022 Q4 | -34.52 Million USD | -3.16% |
| 2022 Q2 | -62.57 Million USD | 0.0% |
| 2022 FY | -882.92 Million CNY | -12.84% |
| 2022 Q3 | -33.46 Million USD | 46.52% |
| 2021 Q2 | -58.2 Million USD | 0.0% |
| 2021 FY | -782.42 Million CNY | -15.47% |
| 2021 Q4 | -62.97 Million USD | 0.0% |
| 2020 FY | -677.6 Million CNY | 54.24% |
| 2020 Q2 | -45.44 Million USD | 0.0% |
| 2020 Q4 | -52.89 Million USD | 0.0% |
| 2019 Q2 | -93.7 Million USD | 0.0% |
| 2019 Q4 | -121.08 Million USD | 0.0% |
| 2019 FY | -1.48 Billion CNY | -328.81% |
| 2018 FY | -345.3 Million CNY | -191.36% |
| 2017 FY | -118.51 Million CNY | -9.9% |
| 2016 FY | -107.83 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -1134.792% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -13975.751% |
| SQZ Biotechnologies Company | -79.46 Million USD | -1064.851% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 1847.177% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 1521.151% |
| Mesoblast Limited | -87.95 Million USD | -952.386% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -50744.425% |
| Genus plc | 7.9 Million USD | 11816.924% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -8398.522% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -24848.211% |
| Marizyme, Inc. | -65.34 Million USD | -1316.497% |
| ContraFect Corporation | -65.15 Million USD | -1320.713% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -10366.271% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -18844.434% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -53483.856% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -31902.452% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -11384.783% |
| MultiCell Technologies, Inc. | -380.07 USD | -243543720.875% |
| Accustem Sciences Inc. | -3.74 Million USD | -24607.247% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -1690.677% |
| EV Biologics, Inc. | -1.26 Million USD | -72949.654% |
| Q BioMed Inc. | -2.05 Million USD | -45006.971% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -24696.062% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -146267.292% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -38778.099% |
| Biomind Labs Inc. | -1.21 Million USD | -76126.84% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -8675.474% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -11612.338% |
| Skye Bioscience, Inc. | -37.64 Million USD | -2358.872% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -42559.739% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -6180702.618% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -13155.889% |
| IMV Inc. | -36.48 Million USD | -2436.986% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -5732.091% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -15811.926% |
| GB Sciences, Inc. | -1.36 Million USD | -67877.722% |
| Alpha Cognition Inc. | -13.77 Million USD | -6620.875% |
| HST Global, Inc. | -146.21 Thousand USD | -632987.34% |
| CSL Limited | 2.64 Billion USD | 135.035% |
| Halberd Corporation | -79.67 Thousand USD | -1161651.343% |
| Enzolytics Inc. | -2.17 Million USD | -42422.207% |
| Resverlogix Corp. | -3.61 Million USD | -25540.914% |
| Affymax, Inc. | -14.42 Million USD | -6317.339% |
| SYBLEU INC | -180.3 Thousand USD | -513275.743% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -29086.684% |
| argenx SE | -295.05 Million USD | -213.719% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -1378.677% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 944627.551% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -23198.229% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -30488.093% |
| AVAX Technologies, Inc. | -6.41 Million USD | -14332.301% |
| Zenith Capital Corp. | -10.59 Million USD | -8635.721% |
| Genscript Biotech Corporation | -95.47 Million USD | -869.487% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -3982504.767% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -22226.37% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -1531381.896% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -1449.821% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -29742.238% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -87550.288% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -47386.853% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -24137.68% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -46063.786% |
| BioStem Technologies, Inc. | -8.48 Million USD | -10811.691% |
| ONE Bio Corp. | 8.67 Million USD | 10768.185% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -209619.532% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -69213.727% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -52649.732% |
| Agentix Corp. | -1.37 Million USD | -67257.706% |
| LadRx Corporation | 400.44 Thousand USD | 231253.248% |
| Cell Source, Inc. | -5.32 Million USD | -17295.229% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -222687.915% |
| Regen BioPharma, Inc. | 1.02 Million USD | 90537.691% |
| Regen BioPharma, Inc. | 1.02 Million USD | 90537.691% |
| NovAccess Global Inc. | -4.76 Million USD | -19308.696% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 13467.383% |
| Itoco Inc. | -1.86 Million USD | -49425.922% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -20735.784% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -55360.575% |
| Kadimastem Ltd | -3.3 Million USD | -27886.865% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -338462.629% |
| CytoDyn Inc. | -49.84 Million USD | -1757.18% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -1171103.168% |
| Mobile Lads Corp. | -2.26 Million USD | -40797.816% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -405655.128% |
| Qrons Inc. | -789.34 Thousand USD | -117166.171% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -98212.107% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -44238.027% |
| Rebus Holdings, Inc. | -1.02 Million USD | -90648.725% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -57295.409% |
| International Stem Cell Corporation | -131 Thousand USD | -706493.13% |
| Bioxytran, Inc. | -4.28 Million USD | -21527.023% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -1705451.666% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -36482.871% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -1825.522% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -43686.045% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -118436.613% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -29118.34% |
| Neutra Corp. | -233.46 Thousand USD | -396377.845% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -4461.811% |
| PureTech Health plc | -65.69 Million USD | -1308.949% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -4252.552% |
| IXICO plc | -1.17 Million USD | -78476.995% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -9224.438% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -1520.286% |
| CSL Limited | 2.64 Billion USD | 135.035% |
| Cellectis S.A. | -103.17 Million USD | -797.162% |